Kezar Life Sciences (NASDAQ:KZR) Price Target Cut to $13.00

Kezar Life Sciences (NASDAQ:KZR – Get Rating) had its price target lowered by Wells Fargo & Company from $14.00 to $13.00 in a research report report published on Friday, The Fly reports. Several other brokerages have also recently weighed in on KZR. HC Wainwright reduced their price objective on Kezar Life Sciences from $21.00 to […]

Related Keywords

Arizona ,United States ,William Blair ,John Fowler ,Christopherj Kirk ,Sg Americas Securities ,Wells Fargo Company ,Manufacturers Life Insurance Company ,Dimensional Fund Advisors ,Kezar Life Sciences Stock ,Kezar Life Sciences Company Profile ,Charles Schwab Investment Management Inc ,News Ratings For Kezar Life Sciences Daily ,Kezar Life Sciences ,Kezar Life Sciences Inc ,Get Rating ,Wells Fargo ,Life Sciences ,Schwab Investment Management ,Fund Advisors ,Arizona State Retirement System ,State Retirement System ,Jack Taunton ,South San Francisco ,Kezar Life Sciences Daily ,Nasdaq Kzr ,Kzr ,Medical ,Lower Price Target ,